{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:43:44Z","timestamp":1775040224130,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11606-022-07486-5","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T14:04:18Z","timestamp":1647957858000},"page":"4183-4188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD"],"prefix":"10.1007","volume":"37","author":[{"given":"Nour","family":"Baalbaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-785X","authenticated-orcid":false,"given":"Christopher","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie L.","family":"Hartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramodini","family":"Kale-Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"7486_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1055\/s-0035-1555607","volume":"36","author":"SR Rosenberg","year":"2015","unstructured":"Rosenberg SR, Kalhan R, Mannino DM. Epidemiology of chronic obstructive pulmonary disease: prevalence, morbidity, mortality, and risk factors. Semin Respir Crit Care Med. 2015;36:457-469.","journal-title":"Semin Respir Crit Care Med"},{"key":"7486_CR2","unstructured":"GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021 Report. Available at https:\/\/goldcopd.org\/wp-content\/uploads\/2020\/11\/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed June 1, 2021."},{"key":"7486_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.rmed.2018.03.035","volume":"138","author":"N Naderi","year":"2018","unstructured":"Naderi N, Assayag D, Mostafavi-Pour-Manshadi SM, et al. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease. Respir Med. 2018;138:129-136.","journal-title":"Respir Med"},{"key":"7486_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12890-017-0541-0","volume":"17","author":"HL Zhang","year":"2017","unstructured":"Zhang HL, Tan M, Qiu AM, Tao Z, Wang CH. Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis. BMC\u200b Pulm Med\u200b. 2017;17:196.","journal-title":"BMC\u200b Pulm Med"},{"key":"7486_CR5","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMra0800353","volume":"359","author":"S Sethi","year":"2008","unstructured":"Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359:2355-2365.","journal-title":"N Engl J Med."},{"key":"7486_CR6","doi-asserted-by":"publisher","unstructured":"Feldman C, Richards G. Appropriate antibiotic management of bacterial lower respiratory tract infections. F1000Res\u200b\u200b. 2018;7:F1000 Faculty Rev-1121. Published 2018 Jul 23. https:\/\/doi.org\/10.12688\/f1000research.14226.1","DOI":"10.12688\/f1000research.14226.1"},{"key":"7486_CR7","first-page":"329","volume":"8","author":"HI Yoon","year":"2013","unstructured":"Yoon HI, Lee CH, Kim DK, et al. Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:329-334.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"issue":"4","key":"7486_CR8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1513\/pats.200707-088ET","volume":"5","author":"N MacIntyre","year":"2008","unstructured":"MacIntyre N, Huang YC. Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):530-535. https:\/\/doi.org\/10.1513\/pats.200707-088ET","journal-title":"Proc Am Thorac Soc."},{"issue":"1","key":"7486_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0897190020938190","volume":"35","author":"KR Joyner","year":"2022","unstructured":"Joyner KR, Walkerly A, Seidel K, et al. Comparison of narrow-versus broad-spectrum antibiotics in elderly patients with acute exacerbations of chronic obstructive pulmonary disease. J Pharm Pract. 2022;35(1):26-31. https:\/\/doi.org\/10.1177\/0897190020938190","journal-title":"J Pharm Pract."},{"key":"7486_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0011-393X(05)80247-4","volume":"53","author":"D Dark","year":"1993","unstructured":"Dark, D. Azithromycin versus cefaclor in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Current therapeutic research. 1993;53: 203-211.","journal-title":"Current therapeutic research."},{"key":"7486_CR11","doi-asserted-by":"publisher","first-page":"31S","DOI":"10.1016\/0002-9343(91)90399-I","volume":"91","author":"D Dark","year":"1991","unstructured":"Dark D. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections. Am J Med. 1991;91:31S-35S.","journal-title":"Am J Med."},{"key":"7486_CR12","doi-asserted-by":"crossref","unstructured":"Klugman KP. Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections. Eur Respir J. 2002;36:3s-8s.","DOI":"10.1183\/09031936.02.00400402"},{"key":"7486_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2147\/COPD.S95501","volume":"11","author":"K Vermeersch","year":"2016","unstructured":"Vermeersch K, Gabrovska M, Deslypere G, et al. The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis. 2016;11:687-696.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"7486_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jhm.628","volume":"5","author":"MB Rothberg","year":"2010","unstructured":"Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Comparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). J Hosp Med. 2010;5:261-267.","journal-title":"J Hosp Med."},{"key":"7486_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jac\/47.1.43","volume":"47","author":"J Wistr\u00f6m","year":"2001","unstructured":"Wistr\u00f6m J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother. 2001;47:43-50.","journal-title":"J Antimicrob Chemother."},{"key":"7486_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cix1085","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66:e1-e48.","journal-title":"Clin Infect Dis."},{"key":"7486_CR17","doi-asserted-by":"crossref","unstructured":"Andre-Alves MR, Jardim JR, Frare e Silva R, Fiss E, Freire DN, Teixeira PJ. Comparison between azithromycin and amoxicillin in the treatment of infectious exacerbation of chronic obstructive pulmonary disease. J Bras Pneumol\u200b. 2007;33:43-50.","DOI":"10.1590\/S1806-37132007000100010"},{"issue":"3","key":"7486_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1179\/joc.1999.11.3.211","volume":"11","author":"S Umut","year":"1999","unstructured":"Umut S, Tutluoglu B, Aydin Tosun G, et al. Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group. J Chemother. 1999;11(3):211-214.","journal-title":"J Chemother."},{"issue":"3","key":"7486_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/phar.2221","volume":"39","author":"TH Kiser","year":"2019","unstructured":"Kiser TH, Reynolds PM, Moss M, et al. Impact of macrolide antibiotics on hospital readmissions and other clinically important outcomes in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease: a propensity score-matched cohort study. Pharmacotherapy. 2019;39(3):242-252. https:\/\/doi.org\/10.1002\/phar.2221","journal-title":"Pharmacotherapy."},{"key":"7486_CR20","doi-asserted-by":"publisher","first-page":"636157","DOI":"10.1155\/2012\/636157","volume":"2012","author":"B Kwiatkowska","year":"2012","unstructured":"Kwiatkowska B, Ma\u015bli\u0144ska M. Macrolide therapy in chronic inflammatory diseases. Mediators Inflamm. 2012;2012:636157. https:\/\/doi.org\/10.1155\/2012\/636157","journal-title":"Mediators Inflamm."},{"issue":"8","key":"7486_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa1104623","volume":"365","author":"RK Albert","year":"2011","unstructured":"Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD [published correction appears in N Engl J Med. 2012 Apr 5;366(14):1356]. N Engl J Med. 2011;365(8):689-698. https:\/\/doi.org\/10.1056\/NEJMoa1104623","journal-title":"N Engl J Med."},{"issue":"5","key":"7486_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-2600(14)70019-0","volume":"2","author":"S Uzun","year":"2014","unstructured":"Uzun S, Djamin RS, Kluytmans JA, et al. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2014;2(5):361-368. https:\/\/doi.org\/10.1016\/S2213-2600(14)70019-0","journal-title":"Lancet Respir Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07486-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-022-07486-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07486-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:06:17Z","timestamp":1744196777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-022-07486-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":22,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7486"],"URL":"https:\/\/doi.org\/10.1007\/s11606-022-07486-5","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}